PRMT5 and lung carcinoma: To probe the molecular basis of EMT and metastasis in lung cancer cells mediated by PRMT5, the ASTC-a-1 cells were treated with PRMT5 inhibitor GSK591 or infected with lentivirus expressing PRMT5-shRNA, and the EMT markers were monitored by immunofluorescence.